ifosfamide has been researched along with Agranulocytosis in 15 studies
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phase II trial in metastatic urothelial carcinoma using a novel combination chemotherapy regimen consisting of vinblastine, ifosfamide, and gallium nitrate (VIG)." | 9.07 | Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma. ( Ansari, R; Dreicer, R; Einhorn, LH; Gonin, R; Loehrer, PJ; Roth, BJ, 1994) |
| "The purpose of this study was to evaluate the activity of ifosfamide (isophosphamide) in patients with advanced or recurrent leiomyosarcoma not previously exposed to chemotherapy." | 7.68 | Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. ( Barrett, RJ; Blessing, JA; McGehee, R; Sutton, GP, 1992) |
| "Phase II trial in metastatic urothelial carcinoma using a novel combination chemotherapy regimen consisting of vinblastine, ifosfamide, and gallium nitrate (VIG)." | 5.07 | Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma. ( Ansari, R; Dreicer, R; Einhorn, LH; Gonin, R; Loehrer, PJ; Roth, BJ, 1994) |
| "The purpose of this study was to evaluate the activity of ifosfamide (isophosphamide) in patients with advanced or recurrent leiomyosarcoma not previously exposed to chemotherapy." | 3.68 | Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. ( Barrett, RJ; Blessing, JA; McGehee, R; Sutton, GP, 1992) |
| "The pharmacokinetics of ifosfamide were studied in 20 patients with soft tissue and bone sarcomas." | 3.68 | Clinical pharmacokinetics of ifosfamide in combination with N-acetylcysteine. ( Ayele, W; Benvenuto, JA; Legha, SS; Newman, RA; Nicaise, C; Raber, MN, 1992) |
| "Grade 3 thrombocytopenia was observed in five cases (36%)." | 2.71 | Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report. ( Kitamura, T; Kume, H; Matsumoto, S; Nishimatsu, H; Okamoto, N; Suzuki, M; Takahashi, S; Tomita, K, 2005) |
| "Granulocytopenia was the dose-limiting toxicity." | 2.68 | Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. ( Benner, SE; Hong, WK; Huber, MH; Lippman, SM, 1995) |
| "Paclitaxel dose levels were 135, 170, 200, 250, and 300 mg/m2." | 2.68 | Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. ( Bitran, JD; Drinkard, LC; Golomb, HM; Hoffman, PC; Krauss, SA; Masters, GA; Samuels, BL; Vokes, EE; Watson, S, 1995) |
| "Ifosfamide is an active agent in recurrent squamous cell carcinoma of the head and neck." | 2.68 | A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck. ( Benner, SE; Dimery, IW; Dunnington, JS; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M, 1996) |
| "Ifosfamide has shown promising single-agent activity in non-small cell lung cancer (NSCLC)." | 1.28 | Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer. ( Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (86.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, S | 1 |
| Suzuki, M | 1 |
| Kume, H | 1 |
| Matsumoto, S | 1 |
| Okamoto, N | 1 |
| Nishimatsu, H | 1 |
| Tomita, K | 1 |
| Kitamura, T | 1 |
| Benner, SE | 2 |
| Lippman, SM | 2 |
| Huber, MH | 2 |
| Hong, WK | 3 |
| Einhorn, LH | 2 |
| Roth, BJ | 1 |
| Ansari, R | 2 |
| Dreicer, R | 1 |
| Gonin, R | 2 |
| Loehrer, PJ | 2 |
| Hoffman, PC | 1 |
| Krauss, SA | 1 |
| Drinkard, LC | 1 |
| Masters, GA | 1 |
| Samuels, BL | 1 |
| Bitran, JD | 1 |
| Golomb, HM | 1 |
| Watson, S | 1 |
| Vokes, EE | 1 |
| Faylona, EA | 1 |
| Sandler, AB | 1 |
| Evans, WK | 2 |
| Stewart, DJ | 1 |
| Shepherd, FA | 2 |
| Logan, D | 2 |
| Goss, G | 1 |
| Maroun, JA | 1 |
| Wierzbicki, R | 1 |
| Warner, E | 2 |
| Latreille, J | 2 |
| Dahrouge, S | 1 |
| Shirinian, M | 2 |
| Dimery, IW | 1 |
| Dunnington, JS | 1 |
| Haim, N | 1 |
| Ben-Shahar, M | 1 |
| Faraggi, D | 1 |
| Tsuri-Etzioni, A | 1 |
| Leviov, M | 1 |
| Epelbaum, R | 1 |
| Kleiner, S | 1 |
| Kirsch, A | 1 |
| Schwaner, I | 1 |
| Kingreen, D | 1 |
| Schwella, N | 1 |
| Huhn, D | 1 |
| Siegert, W | 1 |
| Dodd, PM | 1 |
| McCaffrey, JA | 1 |
| Hilton, S | 1 |
| Mazumdar, M | 1 |
| Herr, H | 1 |
| Kelly, WK | 1 |
| Icasiano, E | 1 |
| Boyle, MG | 1 |
| Bajorin, DF | 1 |
| Lee, JS | 1 |
| Dhingra, HH | 1 |
| Greenberg, J | 1 |
| Goss, PE | 1 |
| Maroun, J | 1 |
| Stewart, D | 1 |
| Paul, K | 1 |
| Sutton, GP | 1 |
| Blessing, JA | 1 |
| Barrett, RJ | 1 |
| McGehee, R | 1 |
| Benvenuto, JA | 1 |
| Ayele, W | 1 |
| Legha, SS | 1 |
| Raber, MN | 1 |
| Nicaise, C | 1 |
| Newman, RA | 1 |
| Ohnoshi, T | 1 |
| Ueoka, H | 1 |
| Kodani, T | 1 |
| Kamei, H | 1 |
| Kimura, I | 1 |
10 trials available for ifosfamide and Agranulocytosis
| Article | Year |
|---|---|
Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bo | 2005 |
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1995 |
Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cal | 1994 |
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-C | 1995 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1995 |
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Female; H | 1996 |
Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy P | 1997 |
High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Tran | 1997 |
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Topics: Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic | 2000 |
[Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
Topics: Adenocarcinoma; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No | 1990 |
5 other studies available for ifosfamide and Agranulocytosis
| Article | Year |
|---|---|
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1994 |
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1992 |
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma | 1992 |
Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Agranulocytosis; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide | 1992 |
Clinical pharmacokinetics of ifosfamide in combination with N-acetylcysteine.
Topics: Acetylcysteine; Agranulocytosis; Bone Marrow; Humans; Ifosfamide; Sarcoma | 1992 |